Redefining and Refining the Treatment Approaches to Cardiovascular Medicine

If you have taken this course and used it for consultant credit in a previous renewal cycle you cannot take this course again.  If you do not know which course you took for a previous consultant renewal cycle please refer to your CE Broker profile

enroll now button


Intended Audience
Pharmacists

ACPE Universal Activity Number
0012-0000-16-066-H01-P

Activity Type
Knowledge

CE Hours
12 (General or Consultant Recertification)

Price
$169.00

Dates Available
02/10/2016 – 02/10/2019

Authors
Rhonda Cooper-DeHoff, PharmD, MS, FACC, FAHA
Associate Professor of Pharmacy and Medicine
University of Florida, Gainesville, FL

Larry Lopez, PharmD, FCCP,
Professor Emeritus of Pharmacy and Medicine
University of Florida, Gainesville, FL

David Parra, PharmD, FCCP, BCPS (AQ Cardiology)
Clinical Pharmacy Specialist, Cardiology
Veterans Affairs Medical Center, West Palm Beach, FL

Augustus (Rob) Hough IV, PharmD, BCPS (AQ Cardiology)
Ambulatory Care Clinical Pharmacy Specialist/Associate Director PGY2 Cardiology Pharmacy Residency Program
Veterans Affairs Medical Center, West Palm Beach, FL

Kevin Clauson, PharmD
Associate Professor Lipscomb
University College of Pharmacy, Nashville, TN

Jacintha Cauffield, PharmD, BCPS
Associate Professor of Pharmacy
Palm Beach Atlantic University, West Palm Beach, FL

Douglas Jennings, PharmD, AACC, BCPS (AQ Cardiology)
Assistant Professor of Pharmacy Practice
Nova Southeastern University, Ft. Lauderdale, FL

 


Summary

This course will cover working within the many guidelines currently available in the treatment of cardiovascular diseases, including hypertension, dyslipidemia, anticoagulation, ischemic heart disease and others. Course materials will help pharmacists in their quest for more effective drug therapy management knowledge and skills.

This homestudy course is approved by the Florida Board of Pharmacy for 12 consultant recertification hours. 

Objectives

  • Recognize the primary genetic defects and secondary causes of dyslipidemia.
  • Describe the development and complications of atherosclerotic cardiovascular disease.
  • Apply 2013 ACC/AHA Guidelines on the treatment of blood cholesterol for patients who may have, or who may be at risk for atherosclerotic cardiovascular disease.
  • Design an appropriate treatment regimen, considering a patient’s age, history and lipid profile, for primary and secondary prevention of atherosclerotic cardiovascular disease.
  • Identify hypertension-related target organ damage and state treatment regimens designed to prevent this damage.
  • State the overall goals for treating hypertension and identify specific blood pressure goals for patients when given patient information.
  • Describe individual considerations for antihypertensive management in elderly and very elderly patients, African American patients, children and adolescents, patients with erectile dysfunction, and in pregnancy.
  • Determine and list appropriate therapy according to the 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults (JNC 8).
  • Describe the epidemiology and pathophysiology of ischemic heart disease.
  • Discuss appropriate treatment modalities for ischemic heart disease and, as a team participant, determine an appropriate pharmacotherapeutic plan of treatment for this condition.
  • Compare target-specific oral anticoagulants (TSOACs) with vitamin K antagonists and low molecular weight heparin in advantages and disadvantages.
  • Review the mechanism of action and pharmacokinetics of TSOACs.
  • Discuss the American Heart Association Cardiovascular Risk Calculator and demonstrate its use in determining the risk for three people of varying ages.
  • Demonstrate the NIH Risk Assessment Tool for estimating a person’s 10-year risk of myocardial infarction based on Framingham Heart Study information.

Schedule of Activities

View all eight module recorded lectures, read the supplemental documents and receive 70% or higher on all eight module quizzes.

Requirements for Successful Course Completion

View all eight module recorded lectures, read the supplemental documents, receive 70% or higher on all eight module quizzes. and submit a course evaluation.

The University of Florida College of Pharmacy will report CPE credit to CPE Monitor and CE Broker when applicable. If you would like a paper statement of credit, you may print it from your NABP e-profile.

Program Financial Support

This course received no outside funding support.

Computer Requirements

Computer and Internet access are required to complete this course. Course content is provided via Canvas.

The minimum hardware, software, and Internet requirements for Canvas can be found here.

Policies

Refund Policy for CE Courses

Privacy and Confidentiality Policy

Copyright

This course  in its entirety is copyrighted by the University of Florida Continuing Pharmacy Education and may not be duplicated or reproduced for any other purpose without specific written permission.

Contact Information

Please contact Continuing Pharmacy Education at cesupport@ahc.ufl.edu


ACPE LogoThe University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.